PL2037937T3 - Tri i tetra-oligosacharydy do stosowania jako środki aglutynujące patogeny jelitowe - Google Patents

Tri i tetra-oligosacharydy do stosowania jako środki aglutynujące patogeny jelitowe

Info

Publication number
PL2037937T3
PL2037937T3 PL07729609T PL07729609T PL2037937T3 PL 2037937 T3 PL2037937 T3 PL 2037937T3 PL 07729609 T PL07729609 T PL 07729609T PL 07729609 T PL07729609 T PL 07729609T PL 2037937 T3 PL2037937 T3 PL 2037937T3
Authority
PL
Poland
Prior art keywords
saccharides
oligo
tetra
tri
enteric pathogens
Prior art date
Application number
PL07729609T
Other languages
English (en)
Inventor
Geert Bruggeman
Katrien Deschepper
Original Assignee
Nutrition Sciences N V /S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition Sciences N V /S A filed Critical Nutrition Sciences N V /S A
Publication of PL2037937T3 publication Critical patent/PL2037937T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL07729609T 2006-05-30 2007-05-29 Tri i tetra-oligosacharydy do stosowania jako środki aglutynujące patogeny jelitowe PL2037937T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06447074 2006-05-30
EP07729609.3A EP2037937B1 (en) 2006-05-30 2007-05-29 Tri and tetra-oligo-saccharides for use as agglutination agents for enteric pathogens
PCT/EP2007/055187 WO2007138047A2 (en) 2006-05-30 2007-05-29 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens

Publications (1)

Publication Number Publication Date
PL2037937T3 true PL2037937T3 (pl) 2015-10-30

Family

ID=38654620

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07729609T PL2037937T3 (pl) 2006-05-30 2007-05-29 Tri i tetra-oligosacharydy do stosowania jako środki aglutynujące patogeny jelitowe

Country Status (11)

Country Link
US (1) US8729051B2 (pl)
EP (1) EP2037937B1 (pl)
JP (1) JP5393450B2 (pl)
CN (1) CN101454011B (pl)
BR (1) BRPI0711792A2 (pl)
CA (1) CA2652735C (pl)
DK (1) DK2037937T3 (pl)
ES (1) ES2542504T3 (pl)
PL (1) PL2037937T3 (pl)
SI (1) SI2037937T1 (pl)
WO (1) WO2007138047A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1019290A5 (nl) 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.
GB201415776D0 (en) 2014-09-05 2014-10-22 Singh Ishwar And Taylor Edward New antibacterial products
CN110753550A (zh) * 2017-06-14 2020-02-04 嘉吉公司 包含甘露糖寡糖的组合物及其制备方法和用途
JP7382011B2 (ja) 2018-03-16 2023-11-16 味の素株式会社 飼料用添加剤及び飼料

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859488A (en) 1987-09-15 1989-08-22 Kabushiki Kaisha Yakult Honsha Liquid food for curing constipation: polydextrose and oligosaccharide
US4902674A (en) 1987-10-13 1990-02-20 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
JPH04266827A (ja) * 1991-02-20 1992-09-22 Sanyo Chem Ind Ltd 抗菌剤
JPH06205669A (ja) 1992-08-04 1994-07-26 Aomori Pref Gov 微生物に対する選択的増殖剤および選択的静菌剤
AU1908095A (en) * 1993-12-23 1995-07-10 Nutreco Nederland B.V. The use of mannan-rich materials in feedstuffs
JP3054750B2 (ja) * 1994-02-24 2000-06-19 有限会社生物科学産業研究所 マンノオリゴ糖類含有飼料
JPH0838064A (ja) * 1994-07-26 1996-02-13 Meiji Seika Kaisha Ltd 有害細菌の感染を予防する飼料
JPH08173055A (ja) * 1994-12-21 1996-07-09 Shinichi Hoshida マンノース系多糖体含有飼料
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
US6069137A (en) 1996-03-11 2000-05-30 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5939397A (en) 1996-04-18 1999-08-17 Synsorb Biotech, Inc. Treatment of cholera
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
JP2000217546A (ja) * 1999-01-29 2000-08-08 Showa Sangyo Co Ltd マンノース含有ヘテロオリゴ糖からなる甘味剤、病原菌感染抑制剤、整腸剤又は澱粉の老化抑制剤及び該剤からなる飲食品、医薬品又は飼料。
JP3951545B2 (ja) * 1999-03-23 2007-08-01 王子製紙株式会社 キシロオリゴ糖の製造方法
JP3553866B2 (ja) 1999-09-14 2004-08-11 味の素ゼネラルフーヅ株式会社 マンノオリゴ糖類を主成分とする組成物
JP2004159659A (ja) * 1999-09-14 2004-06-10 Ajinomoto General Foods Inc マンノオリゴ糖類を主成分とする組成物
FR2802536B1 (fr) * 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
DE19961182B4 (de) * 1999-12-18 2006-01-12 Südzucker AG Mannheim/Ochsenfurt Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung
JP4078778B2 (ja) * 2000-02-10 2008-04-23 王子製紙株式会社 キシロオリゴ糖組成物
JP2001231591A (ja) * 2000-02-28 2001-08-28 Unitika Ltd マンノース及び/又はマンノオリゴ糖の製造方法
CN1353996A (zh) * 2000-11-21 2002-06-19 庄鲁江 一种双向调理肠胃的药物
JP2003034650A (ja) * 2001-07-19 2003-02-07 National Institute Of Infectious Diseases 腸管感染症予防化合物及びそれを含む飲食物
JP4073661B2 (ja) * 2001-12-20 2008-04-09 王子製紙株式会社 酸性キシロオリゴ糖組成物の製造方法
JP3751914B2 (ja) * 2002-07-15 2006-03-08 三菱スペース・ソフトウエア株式会社 医用画像処理方法及びその装置
FI20021989A0 (fi) 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
JP4294302B2 (ja) * 2002-11-28 2009-07-08 伊藤忠飼料株式会社 α−マンノビオース含有飼料
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0303716D0 (en) * 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
CN1596727A (zh) * 2003-09-16 2005-03-23 江门量子高科生物工程有限公司 一种功能复合糖及其生产方法

Also Published As

Publication number Publication date
CN101454011A (zh) 2009-06-10
DK2037937T3 (en) 2015-07-20
WO2007138047A2 (en) 2007-12-06
JP5393450B2 (ja) 2014-01-22
SI2037937T1 (sl) 2015-09-30
BRPI0711792A2 (pt) 2011-12-06
US20090186852A1 (en) 2009-07-23
EP2037937B1 (en) 2015-04-22
CA2652735A1 (en) 2007-12-06
JP2009538872A (ja) 2009-11-12
EP2037937A2 (en) 2009-03-25
CN101454011B (zh) 2013-01-16
CA2652735C (en) 2015-07-28
ES2542504T3 (es) 2015-08-06
WO2007138047A3 (en) 2008-07-10
US8729051B2 (en) 2014-05-20

Similar Documents

Publication Publication Date Title
HUS2300039I1 (hu) PSMA-kötõ szerek és alkalmazásaik
HK1183435A1 (en) Frizzled-binding agents and uses thereof
PT2056752T (pt) Luva de reforço
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
EP2048195A4 (en) INORGANIC ORGANIC HYBRID COMPOSITION AND USE THEREOF
EP2064962A4 (en) GLOVE
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
PT2853293T (pt) Compostos de tionínio e a sua utilização
EP2250551A4 (en) PROCEDURE LAYOUT AND SPLITTING ON BLOCK COUNTING BASIS
EP2044551A4 (en) CASCADED SPINE SIMULATION
EP2072925A4 (en) SAFE EXHAUST SYSTEM
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
PL2061458T3 (pl) Kompozycje topiramatu i sposoby ich stosowania
GB0603975D0 (en) Methods and agents for reducing oxidative stress
EP2084528A4 (en) TESTS AND DEVICES FOR THE IDENTIFICATION OF DISEASES OF DISEASE
SI2037937T1 (sl) Tri in tetra-oligosaharidi za uporabo kot aglutinacijska sredstva za enterične patogene
GB0623864D0 (en) Grip device
EP2211841A4 (en) PROPHYLAXIS METHOD AND AGENTS FOR USE IN THIS METHOD
EP2068747A4 (en) DENTISTRY INSULATOR
GB0910053D0 (en) Assav devices and methods and components for use therein
GB0624003D0 (en) Stretcher
ZA200905465B (en) Calcium reducing agents and methods
HU3431U (en) Sequential isolator
GB2437523B (en) Walls and components thereof
TWM300458U (en) Gloves